United States Obesity Market Analysis and Competitive Landscape Report 2022

Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) — The “US Obesity Market and Competitive Landscape – 2022” report has been added to



The report provides comprehensive insights into obesity pipeline products, obesity epidemiology, obesity market valuations and forecast, obesity drug sales and competitive landscape in the US.

The research is classified into seven sections – obesity treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drug sales and market shares.

Research Scope:

  • Obesity pipeline: Find out the products in clinical trials for the treatment of obesity by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products

  • Obesity epidemiology: Find out the number of patients diagnosed (prevalence) with obesity in the US

  • Obesity drugs: Identify key products marketed and prescribed for obesity in the US, including trade name, molecule name, and company

  • Obesity drugs sales: Find out the sales revenues of obesity drugs in the US

  • Obesity market valuations: Find out the market size for obesity drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027

  • Obesity drugs market share: Find out the market shares for key obesity drugs in the US

Benefits of this research:

  • Support monitoring and reporting national obesity market analysis and sales trends

  • Track competitor drug sales and market share in the US obesity market

  • Track competitive developments in obesity market and present key issues and learnings

  • Synthesize insights for obesity market and products to drive business performance

  • Answer key business questions about the obesity market

  • Evaluate commercial market opportunity assessment, positioning, and segmentation for obesity products

  • Supports decision making in R&D to long term marketing strategies

Key Data

List of Tables

1. Obesity Phase 3 Clinical Trials, 2022

2. Obesity Phase 2 Clinical Trials, 2022

3. Obesity Phase 1 Clinical Trials, 2022

4. Obesity Epidemiology, US, 2021 – 2027

5. Marketed Drugs for Obesity, US, 2021

6. Obesity Market Size and Forecast ($), US, 2019 – 2027

7. Obesity Drugs Sales ($), US, 2019 – 2027

List of Figures

1. Obesity Epidemiology, US, 2021 – 2027

2. Obesity Market Size and Forecast ($), US, 2019 – 2027

3. Obesity Drugs Market Share (%), US, 2021

For more information about this report visit https://www.researchandmarkets.com/r/jrv5f3-obesity-market?w=12

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900 

Primary Logo

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button